These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8005129)
1. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Keech A; Collins R; MacMahon S; Armitage J; Lawson A; Wallendszus K; Fatemian M; Kearney E; Lyon V; Mindell J Eur Heart J; 1994 Feb; 15(2):255-69. PubMed ID: 8005129 [TBL] [Abstract][Full Text] [Related]
2. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators. Simons LA Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112 [TBL] [Abstract][Full Text] [Related]
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Lansberg PJ; Mitchel YB; Shapiro D; Kastelein JJ; Altman R; Jerums G; Bolzano K; Giannini S; Davignon J; DeWailly P Atherosclerosis; 1995 Aug; 116(2):153-62. PubMed ID: 7575771 [TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group. Mitropoulos KA; Armitage JM; Collins R; Meade TW; Reeves BE; Wallendszus KR; Wilson SS; Lawson A; Peto R Eur Heart J; 1997 Feb; 18(2):235-41. PubMed ID: 9043839 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study]. Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811 [TBL] [Abstract][Full Text] [Related]
9. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811 [TBL] [Abstract][Full Text] [Related]
10. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J; 1999 May; 20(10):725-41. PubMed ID: 10329064 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003 [TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101 [TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Kjekshus J; Pedersen TR Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989 [TBL] [Abstract][Full Text] [Related]
15. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. Mölgaard J; von Schenck H; Olsson AG Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group. Am J Cardiol; 1993 Jun; 71(16):1408-14. PubMed ID: 8517385 [TBL] [Abstract][Full Text] [Related]
17. Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study Group. Itoh T; Matsumoto M; Hougaku H; Handa N; Tsubakihara Y; Yamada Y; Imaizumi M; Hoshi M; Shimazu Y; Hori M; Kawamori R; Ueda N; Fusamoto H; Kamada T Clin Ther; 1997; 19(3):487-97. PubMed ID: 9220213 [TBL] [Abstract][Full Text] [Related]
18. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia. Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688 [TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and efficacy of simvastatin and fenofibrate--a multicenter study. Simvastatin-Fenofibrate Study Group. Ziegler O; Drouin P Cardiology; 1990; 77 Suppl 4():50-7. PubMed ID: 2073672 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). The European Study Group. Am J Cardiol; 1992 Nov; 70(15):1281-6. PubMed ID: 1442579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]